Free Trial

Bicara Therapeutics (BCAX) Earnings Date, Estimates & Call Transcripts

Bicara Therapeutics logo
$11.45 +0.07 (+0.62%)
Closing price 04:00 PM Eastern
Extended Trading
$11.46 +0.01 (+0.09%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bicara Therapeutics Earnings Summary

Upcoming
Earnings Date
Jun. 26Before Market OpensEstimated
Consensus EPS
(Mar. 27)
-$0.31
Actual EPS
(Mar. 27)
-$0.39 Missed By -$0.08

Bicara Therapeutics issued Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.39, which missed the consensus estimate of -$0.31 by $0.08. With a trailing EPS of $0.00, Bicara Therapeutics' earnings are expected to grow next year, from ($2.59) to ($1.74) per share.

Q4 2024 Earnings Resources

BCAX Upcoming Earnings

Bicara Therapeutics' next earnings date is estimated for Thursday, June 26, 2025, based on past reporting schedules.

Get Bicara Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bicara Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BCAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

Bicara Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.40-$0.40-$0.40
Q2 20252-$0.42-$0.41-$0.42
Q3 20252-$0.44-$0.42-$0.43
Q4 20251-$0.47-$0.47-$0.47
FY 20257-$1.73-$1.70-$1.72
Q1 20261-$0.45-$0.45-$0.45
Q2 20261-$0.46-$0.46-$0.46
Q3 20261-$0.47-$0.47-$0.47
Q4 20261-$0.49-$0.49-$0.49
FY 20264($1.87)($1.87)($1.87)
Remove Ads

Bicara Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
6/26/2025
(Estimated)
--------
3/27/2025Q4 2024-$0.31-$0.39 -$0.08-$0.39--
11/12/2024--$0.46-$1.60 -$1.14-$1.60--

Bicara Therapeutics Earnings - Frequently Asked Questions

Bicara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 26th, 2025 based off last year's report dates. Learn more on BCAX's earnings history.

In the previous quarter, Bicara Therapeutics (NASDAQ:BCAX) missed the analysts' consensus estimate of ($0.31) by $0.08 with a reported earnings per share (EPS) of ($0.39). Learn more on analysts' earnings estimate vs. BCAX's actual earnings.

Bicara Therapeutics's earnings are expected to grow from ($2.59) per share to ($1.74) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:BCAX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners